CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injectiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00258609
NCT00258609Phase 3Completed
CompareCT.gov

A 12-week Prospective, Double-blinded, Randomized, Multicenter Study of Low Dose and Medium Dose Botulinum Toxin Type A (Dysport® ) Injection for Migraine Prophylaxis.

Department of Medical Services Ministry of Public Health of Thailand·interventional·Posted Nov 24, 2005·Updated Feb 18, 2019

In Brief

A Phase 3 clinical trial evaluating Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection for Migraine Without Aura Prophylaxis. Completed, across 6 sites.

Detailed Summary

The purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine Without Aura Prophylaxis
CountriesThailand
CollaboratorsIpsen, Chiang Mai University

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 24, 2005
Enrollment StartFeb 1, 2003
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 20.6 years ago

Interventions

Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injectiondrug